reading FLOW threads from 2024 and half of it aged badly
Trying to settle this properly because the thread from last year went in circles. The claim: FLOW matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 10 months without either producing anything. What would actually settle it is 3 people measuring the same thing…
SELECT reported a TRIUMPH hazard ratio but the absolute event rate is what changes clinical practice.
phase 2 is not phase 3, smaller n and shorter trial
Strongly agree. Phase 2 is investigational, not conclusive.
STEP, SURMOUNT, SURPASS, SELECT, FLOW, TRIUMPH — read the appendix
STEP, SURMOUNT, SURPASS, SELECT, FLOW, TRIUMPH — read the appendix
Adding to this: hazard ratio is doing more work than the comment implies.
dropout handling matters, especially on GI-heavy populations
STEP, SURMOUNT, SURPASS, SELECT, FLOW, TRIUMPH — read the appendix
Disagree on that part. 96.8% and 96.2% on the same vial is normal.
Yeah, absolute numbers matter more than the press release.
the 15 week readout is different from the 40 week readout